Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04831840 · ClinicalTrials.gov registry record
Recurrent Urinary Tract Infections and the Microbiome
A clinical trial, sponsored by University of Miami.
- Terminated
- Registry status
- 32
- Enrollment target
NCT04831840: Clinical Trial study, sponsored by University of Miami.
NCT04831840 is a clinical trial that was terminated before completion, run by University of Miami. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04831840 was terminated before completion, sponsored by University of Miami.
- TERMINATED
- Registry status
- 32 participants
- Enrollment target
Study Summary
The primary objective is to determine if polymerase chain reaction (PCR) (UTIP™) is more sensitive in identifying urinary tract infections (UTI's) than standard urine cultures.
Primary Outcome
The proportion of uropathogens found on PCR versus urine culture from urine samples.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2021-05-26 |
| Est. Completion | 2023-11-20 |
Why NCT04831840 stopped before completion
NCT04831840 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04831840 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04831840 about?
NCT04831840 is a clinical study titled "Recurrent Urinary Tract Infections and the Microbiome". The primary objective is to determine if polymerase chain reaction (PCR) (UTIP™) is more sensitive in identifying urinary tract infections (UTI's) than standard urine cultures.
What is the current status of trial NCT04831840?
This trial is currently terminated. The enrollment target is 32 participants. The study started on 2021-05-26. Estimated completion is 2023-11-20.
Who is sponsoring clinical trial NCT04831840?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI